In BC, CCL19, as a novel prognostic chemokine, exhibits aberrant high expression, which not only recruits immune cells to create a tumor microenvironment that inhibited for tumor growth and metastasis but also suppress tumor cell migration and invasion (Gu et al., 2023). This evidence concerns the gene CCL19 and neoplasm.